Ping An Biomedical Co (PASW) Registration Filing summary

Management team and governance

• Board includes a Chairperson, General Manager, CEO, CFO, and three independent non-executive directors, all signing as of June 26, 2025.

• Chairperson holds power of attorney for all signatories regarding SEC filings.

• U.S. authorized representative is Cogency Global Inc., signed by Senior Vice President.

Offering details and pricing

• Registration statement filed as Form F-1, with securities to be offered as soon as practicable after effectiveness.

• Amendment No. 7 filed to update exhibits and the exhibit index; no changes to the prospectus or financials.

• Shares previously issued to major shareholders at $0.0001 per share in November 2021.

Underwriters and syndicate

• Form of underwriting agreement included as an exhibit.